Your browser doesn't support javascript.
loading
Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial.
Wu, Yin; Posner, Marshall R; Schumaker, Lisa M; Nikitakis, Nikolaos; Goloubeva, Olga; Tan, Ming; Lu, Changwan; Iqbal, Sana; Lorch, Jochen; Sarlis, Nicholas J; Haddad, Robert I; Cullen, Kevin J.
Affiliation
  • Wu Y; Experimental Therapeutics Program, University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA.
Cancer ; 118(7): 1811-7, 2012 Apr 01.
Article in En | MEDLINE | ID: mdl-22009819
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomaviridae / Carcinoma, Squamous Cell / Biomarkers / Oropharyngeal Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2012 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomaviridae / Carcinoma, Squamous Cell / Biomarkers / Oropharyngeal Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2012 Type: Article Affiliation country: United States